Sunzen Biotech Berhad Past Earnings Performance
Past criteria checks 5/6
Sunzen Biotech Berhad has been growing earnings at an average annual rate of 53.4%, while the Personal Products industry saw earnings growing at 8.9% annually. Revenues have been declining at an average rate of 29.8% per year. Sunzen Biotech Berhad's return on equity is 5.8%, and it has net margins of 6.9%.
Key information
53.4%
Earnings growth rate
52.4%
EPS growth rate
Personal Products Industry Growth | 8.3% |
Revenue growth rate | -29.8% |
Return on equity | 5.8% |
Net Margin | 6.9% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Sunzen Biotech Berhad (KLSE:SUNZEN) Is Doing The Right Things To Multiply Its Share Price
Apr 22Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You
Nov 16Health Check: How Prudently Does Sunzen Biotech Berhad (KLSE:SUNZEN) Use Debt?
Mar 26Is Sunzen Biotech Berhad (KLSE:SUNZEN) Weighed On By Its Debt Load?
Dec 10Revenue & Expenses BreakdownBeta
How Sunzen Biotech Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 98 | 7 | 18 | 0 |
30 Sep 23 | 86 | 5 | 13 | 0 |
30 Jun 23 | 84 | 4 | 13 | 0 |
31 Mar 23 | 92 | 4 | 14 | 0 |
31 Dec 22 | 97 | 4 | 15 | 0 |
30 Sep 22 | 109 | 3 | 12 | 0 |
30 Jun 22 | 103 | 2 | 12 | 0 |
31 Mar 22 | 95 | 2 | 12 | 0 |
31 Dec 21 | 90 | 1 | 11 | 0 |
30 Sep 21 | 89 | -9 | 19 | 0 |
30 Jun 21 | 92 | -9 | 18 | 0 |
31 Mar 21 | 85 | -11 | 16 | 0 |
31 Dec 20 | 82 | -13 | 17 | 0 |
30 Sep 20 | 99 | -17 | 11 | 0 |
30 Jun 20 | 141 | -20 | 14 | 0 |
31 Mar 20 | 195 | -20 | 14 | 0 |
31 Dec 19 | 241 | -18 | 15 | 0 |
30 Sep 19 | 270 | -13 | 16 | 0 |
30 Jun 19 | 307 | -11 | 14 | 0 |
31 Mar 19 | 292 | -8 | 13 | 0 |
31 Dec 18 | 296 | -7 | 10 | 0 |
30 Sep 18 | 325 | 1 | 9 | 0 |
30 Jun 18 | 304 | 3 | 7 | 0 |
31 Mar 18 | 329 | 2 | 6 | 0 |
31 Dec 17 | 303 | 3 | 5 | 0 |
30 Sep 17 | 214 | 6 | 4 | 0 |
30 Jun 17 | 144 | 4 | 4 | 0 |
31 Mar 17 | 78 | 2 | 5 | 0 |
31 Dec 16 | 40 | 0 | 6 | 0 |
30 Sep 16 | 35 | -3 | 8 | 0 |
30 Jun 16 | 33 | -3 | 8 | 0 |
31 Mar 16 | 32 | -2 | 7 | 0 |
31 Dec 15 | 32 | 0 | 6 | 0 |
30 Sep 15 | 34 | 1 | 6 | 0 |
30 Jun 15 | 36 | 1 | 6 | 0 |
31 Mar 15 | 37 | 1 | 7 | 0 |
31 Dec 14 | 37 | 1 | 7 | 0 |
30 Sep 14 | 38 | 2 | 9 | 0 |
30 Jun 14 | 39 | 3 | 9 | 0 |
31 Mar 14 | 38 | 3 | 8 | 0 |
31 Dec 13 | 37 | 4 | 7 | 0 |
30 Sep 13 | 34 | 3 | 6 | 0 |
30 Jun 13 | 33 | 2 | 6 | 0 |
Quality Earnings: SUNZEN has high quality earnings.
Growing Profit Margin: SUNZEN's current net profit margins (6.9%) are higher than last year (3.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SUNZEN has become profitable over the past 5 years, growing earnings by 53.4% per year.
Accelerating Growth: SUNZEN's earnings growth over the past year (81.9%) exceeds its 5-year average (53.4% per year).
Earnings vs Industry: SUNZEN earnings growth over the past year (81.9%) exceeded the Personal Products industry 19%.
Return on Equity
High ROE: SUNZEN's Return on Equity (5.8%) is considered low.